Ron Bentsur - 30 Nov 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
30 Nov 2022
Net transactions value
+$1,118
Form type
4
Filing time
30 Nov 2022, 16:43:13 UTC
Previous filing
29 Nov 2022
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,118 +150 +0% $7.45 3,015,459 30 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.